Azithromycin-Induced Stevens-Johnson Syndrome in a Patient With SARS-CoV-2 and End-Stage Renal Disease.

Azithromycin-Induced Stevens-Johnson Syndrome in a Patient With SARS-CoV-2 and End-Stage Renal Disease.

Publication date: Aug 01, 2025

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are a spectrum of immune-mediated mucocutaneous injuries often due to an adverse reaction to medication or infection. Numerous medications have been associated with SJS, with abacavir, allopurinol, aromatic antiepileptic drugs, minocycline, proton pump inhibitors, and sulfasalazine being the most common. Additionally, there have been several case reports of SJS associated with SARS-CoV-2 infection. The clinical presentation of SJS usually includes atypical targets or purpuric macules, along with oral mucosal involvement. Herein, we present a case of SJS with primary oral mucosal involvement in a patient with end-stage renal disease (ESRD) due to polycystic kidney disease, recent SARS-CoV-2 infection, and azithromycin exposure.

Open Access PDF

Concepts Keywords
Kidney drug reaction
Necrolysis end-stage renal disease
Proton macrolide
Stage sars-cov-2
Toxic stevens-johnson syndrome

Semantics

Type Source Name
drug DRUGBANK Azithromycin
disease MESH Stevens-Johnson Syndrome
disease MESH End-Stage Renal Disease
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH infection
drug DRUGBANK Abacavir
drug DRUGBANK Allopurinol
drug DRUGBANK Minocycline
drug DRUGBANK Sulfasalazine
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH polycystic kidney disease
pathway REACTOME Reproduction
disease MESH adverse drug reactions
disease MESH death
disease IDO immunodeficiency
disease MESH hematological malignancies
disease MESH cancers
disease MESH systemic lupus erythematosus
pathway KEGG Systemic lupus erythematosus
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH chronic kidney diseases
drug DRUGBANK Sulfamethoxazole
drug DRUGBANK Sulfadiazine
drug DRUGBANK Phenytoin
drug DRUGBANK Phenobarbital
drug DRUGBANK Carbamazepine
drug DRUGBANK Nevirapine
drug DRUGBANK Tenoxicam
drug DRUGBANK Meloxicam
drug DRUGBANK Piroxicam
drug DRUGBANK Lamotrigine
disease MESH blister
disease IDO history
disease MESH immune thrombocytopenia
drug DRUGBANK Tamoxifen
disease MESH iron deficiency anemia
disease MESH aphthous stomatitis
disease MESH mouth ulcers
drug DRUGBANK Famotidine
drug DRUGBANK Lisinopril
drug DRUGBANK Omega-3 fatty acids
disease MESH sore throat
drug DRUGBANK Phencyclidine
drug DRUGBANK Methylprednisolone
disease IDO intervention
disease MESH emergency
disease IDO blood
disease MESH erythema
disease MESH ulcers

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *